Arginine metabolic enzymes, nitric oxide and infection

被引:108
作者
Mori, M [1 ]
Gotoh, T [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan
关键词
arginine; arginase; argininosuccinate synthetase; nitric oxide; nitric oxide synthase;
D O I
10.1093/jn/134.10.2820S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Nitric oxide (NO) is synthesized from arginine by NO synthase (NOS), and the availability of arginine is one of the rate-limiting factors in cellular NO production. Citrulline that is formed as a by-product of the NOS reaction can be recycled to arginine by successive actions of argininosuccinate synthetase (AS) and argininosuccinate lyase (AL), forming the citrulline-NO cycle. AS and sometimes AL have been shown to be coinduced with inducible NOS (iNOS) in various cell types including activated macrophages, microglia, vascular smooth muscle cells, glial cells, neuronal PC12 cells, retinal pigment epithelial cells, and pancreatic beta-cells. Coinduction of endothelial NOS (eNOS), AS, and AL are observed in human umbilical vein endothelial cells. In contrast, arginase can downregulate NO production by decreasing intracellular arginine concentrations. NOS and arginase activities are regulated reciprocally in macrophages by cytokines, and this may guarantee the efficient production of NO. In contrast, iNOS and arginase isoforms (type I and/or II) are coinduced in immunostimulated macrophages, but not in PC12 cells and glial cells. These results indicate that NO production is modulated by the recycling and degradation of arginine. Arginase also plays an important role in regulation of polyamine and proline synthesis.
引用
收藏
页码:2820S / 2825S
页数:6
相关论文
共 61 条
[1]   ARGININE METABOLISM IN WOUNDS [J].
ALBINA, JE ;
MILLS, CD ;
BARBUL, A ;
THIRKILL, CE ;
HENRY, WL ;
MASTROFRANCESCO, B ;
CALDWELL, MD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (04) :E459-E467
[2]   Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels [J].
Berkowitz, DE ;
White, R ;
Li, DC ;
Minhas, KM ;
Cernetich, A ;
Kim, S ;
Burke, S ;
Shoukas, AA ;
Nyhan, D ;
Champion, HC ;
Hare, JM .
CIRCULATION, 2003, 108 (16) :2000-2006
[3]   N-OMEGA-HYDROXY-L-ARGININE, AN INTERMEDIATE IN THE L-ARGININE TO NITRIC-OXIDE PATHWAY, IS A STRONG INHIBITOR OF LIVER AND MACROPHAGE ARGINASE [J].
BOUCHER, JL ;
CUSTOT, J ;
VADON, S ;
DELAFORGE, M ;
LEPOIVRE, M ;
TENU, JP ;
YAPO, A ;
MANSUY, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (03) :1614-1621
[4]   L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study [J].
Braissant, O ;
Gotoh, T ;
Loup, M ;
Mori, M ;
Bachmann, C .
MOLECULAR BRAIN RESEARCH, 1999, 70 (02) :231-241
[5]   Arginase 1 overexpression in psoriasis - Limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation [J].
Bruch-Gerharz, D ;
Schnorr, O ;
Suschek, C ;
Beck, KF ;
Pfeilschifter, J ;
Ruzicka, T ;
Kolb-Bachofen, V .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) :203-211
[6]   Arginase activity in endothelial cells: Inhibition by N-G-hydroxy-L-arginine during high-output NO production [J].
Buga, GM ;
Singh, R ;
Pervin, S ;
Rogers, NE ;
Schmitz, DA ;
Jenkinson, CP ;
Cederbaum, SD ;
Ignarro, LJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (05) :H1988-H1998
[7]  
Chang CI, 2001, CANCER RES, V61, P1100
[8]  
Corraliza I, 2002, J RHEUMATOL, V29, P2261
[9]   ACTIVATED MACROPHAGES KILL TUMOR-CELLS BY RELEASING ARGINASE [J].
CURRIE, GA .
NATURE, 1978, 273 (5665) :758-759
[10]   INHIBITION OF RAT-LIVER ARGINASE BY AN INTERMEDIATE IN NO BIOSYNTHESIS, N-G-HYDROXY-L-ARGININE - IMPLICATIONS FOR THE REGULATION OF NITRIC-OXIDE BIOSYNTHESIS BY ARGINASE [J].
DAGHIGH, F ;
FUKUTO, JM ;
ASH, DE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (01) :174-180